{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T11:59:53Z","timestamp":1790769593994,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Seidman Cancer Center"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/j.clml.2018.11.001","type":"journal-article","created":{"date-parts":[[2018,11,12]],"date-time":"2018-11-12T19:43:42Z","timestamp":1542051822000},"page":"73-82","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia"],"prefix":"10.1016","volume":"19","author":[{"given":"Fahrettin","family":"Covut","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Divya","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raisa","family":"Pinto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Dambrosio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Najla","family":"El Jurdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5084-6643","authenticated-orcid":false,"given":"Howard","family":"Meyerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2277-1976","authenticated-orcid":false,"given":"Masumi","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merle","family":"Kolk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Creger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1980-9999","authenticated-orcid":false,"given":"Leland","family":"Metheny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda W.","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo F.","family":"Caimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ehsan","family":"Malek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folashade","family":"Otegbeye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1159-5607","authenticated-orcid":false,"given":"Hillard M.","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcos","family":"De Lima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2407-0973","authenticated-orcid":false,"given":"Benjamin K.","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2018.11.001_bib1","first-page":"7","article-title":"Cancer statistics, 2018","volume":"68","author":"Siegel","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/j.clml.2018.11.001_bib2","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1056\/NEJMra1406184","article-title":"Acute myeloid leukemia","volume":"373","author":"Dohner","year":"2015","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2018.11.001_bib3","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1002\/cncr.28129","article-title":"Outcome of older patients with acute myeloid leukemia: an analysis of SEER data over 3 decades","volume":"119","author":"Thein","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.11.001_bib4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.blre.2017.01.003","article-title":"Bone marrow evaluation for diagnosis and monitoring of acute myeloid leukemia","volume":"31","author":"Percival","year":"2017","journal-title":"Blood Rev"},{"key":"10.1016\/j.clml.2018.11.001_bib5","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1038\/leu.2013.341","article-title":"Rapid rate of peripheral blood blast clearance accurately predicts complete remission in acute myeloid leukemia","volume":"28","author":"Vainstein","year":"2014","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.11.001_bib6","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1182\/blood-2007-07-104091","article-title":"Early peripheral blood blast clearance during induction chemotherapy for acute myeloid leukemia predicts superior relapse-free survival","volume":"110","author":"Elliott","year":"2007","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.11.001_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/ajh.21133","article-title":"Day 14 bone marrow biopsy in predicting complete remission and survival in acute myeloid leukemia","volume":"83","author":"Hussein","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib8","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1182\/blood-2002-02-0532","article-title":"Early blast clearance by remission induction therapy is a major independent prognostic factor for both achievement of complete remission and long-term outcome in acute myeloid leukemia: data from the German AML Cooperative Group (AMLCG) 1992 trial","volume":"101","author":"Kern","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.11.001_bib9","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/ajh.24207","article-title":"Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the \u201c3\u00a0+ 7\u201d induction regimen for acute myeloid leukemia","volume":"90","author":"Ofran","year":"2015","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib10","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1002\/ajh.21996","article-title":"The early reduction of leukemic blasts in bone marrow on day 6 of induction treatment is predictive for complete remission rate and survival in adult acute myeloid leukemia; the results of multicenter, prospective Polish Adult Leukemia Group study","volume":"86","author":"Grosicki","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib11","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.3324\/haematol.12825","article-title":"Kinetics of bone marrow blasts during induction and achievement of complete remission in acute myeloid leukemia","volume":"93","author":"Yanada","year":"2008","journal-title":"Haematologica"},{"key":"10.1016\/j.clml.2018.11.001_bib12","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.leukres.2012.09.016","article-title":"Re-induction therapy decisions based on day 14 bone marrow biopsy in acute myeloid leukemia","volume":"37","author":"Morris","year":"2013","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2018.11.001_bib13","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1182\/blood-2016-03-643544","article-title":"The 2016 revision to the World Health Organization classification of myeloid neoplasms and acute leukemia","volume":"127","author":"Arber","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.clml.2018.11.001_bib14","doi-asserted-by":"crossref","first-page":"620","DOI":"10.7326\/0003-4819-103-4-620","article-title":"Proposed revised criteria for the classification of acute myeloid leukemia. A report of the French-American-British Cooperative Group","volume":"103","author":"Bennett","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/j.clml.2018.11.001_bib15","doi-asserted-by":"crossref","first-page":"4642","DOI":"10.1200\/JCO.2003.04.036","article-title":"Revised recommendations of the International Working Group for Diagnosis, Standardization of Response Criteria, Treatment Outcomes, and Reporting Standards for Therapeutic Trials in Acute Myeloid Leukemia","volume":"21","author":"Cheson","year":"2003","journal-title":"J\u00a0Clin Oncol"},{"key":"10.1016\/j.clml.2018.11.001_bib16","doi-asserted-by":"crossref","first-page":"926","DOI":"10.6004\/jnccn.2017.0116","article-title":"Acute myeloid leukemia, version 3.2017, NCCN clinical practice guidelines in oncology","volume":"15","author":"O'Donnell","year":"2017","journal-title":"J\u00a0Natl Compr Canc Netw"},{"key":"10.1016\/j.clml.2018.11.001_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/0197-2456(96)00075-X","article-title":"A\u00a0note on quantifying follow-up in studies of failure time","volume":"17","author":"Schemper","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/j.clml.2018.11.001_bib18","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1002\/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3","article-title":"Index for rating diagnostic tests","volume":"3","author":"Youden","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.11.001_bib19","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1002\/ajh.24818","article-title":"Day 14 bone marrow examination in the management of acute myeloid leukemia","volume":"92","author":"Terry","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib20","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.leukres.2016.04.013","article-title":"A\u00a0new model to predict remission status in AML patients based on day 14 bone marrow biopsy","volume":"46","author":"Norkin","year":"2016","journal-title":"Leuk Res"},{"key":"10.1016\/j.clml.2018.11.001_bib21","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.clml.2018.01.007","article-title":"Marrow hypocellularity, but not residual blast count or receipt of reinduction chemotherapy, is prognostic on day-14 assessment in acute myeloid leukemia patients with morphologic residual disease","volume":"18","author":"Ollila","year":"2018","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"10.1016\/j.clml.2018.11.001_bib22","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/ajh.24627","article-title":"Bone marrow cellularity at day 14 is the most important predictive factor for response in patients with AML who require double-induction chemotherapy: analysis from a large, single institution experience","volume":"92","author":"Griffin","year":"2017","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib23","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1002\/ajh.24500","article-title":"Peripheral blood blast clearance is an independent prognostic factor for survival and response to acute myeloid leukemia induction chemotherapy","volume":"91","author":"Short","year":"2016","journal-title":"Am J Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib24","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1159\/000443468","article-title":"The time to clearance of peripheral blood blasts predicts complete remission and survival in Chinese adults with acute myeloid leukemia","volume":"135","author":"Li","year":"2016","journal-title":"Acta Haematol"},{"key":"10.1016\/j.clml.2018.11.001_bib25","doi-asserted-by":"crossref","first-page":"5278","DOI":"10.1002\/cncr.27494","article-title":"Early clearance of peripheral blood blasts predicts response to induction chemotherapy in acute myeloid leukemia","volume":"118","author":"Arellano","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/j.clml.2018.11.001_bib26","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/leu.2008.296","article-title":"Early clearance of peripheral blasts measured by flow cytometry during the first week of AML induction therapy as a new independent prognostic factor: a GOELAMS study","volume":"23","author":"Lacombe","year":"2009","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.11.001_bib27","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1097\/MOH.0b013e32835d8207","article-title":"New strategies for the evaluation of the nadir bone marrow following induction in acute myeloid leukemia","volume":"20","author":"Mattison","year":"2013","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/j.clml.2018.11.001_bib28","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1038\/leu.2015.255","article-title":"Peripheral blood minimal residual disease may replace bone marrow minimal residual disease as an immunophenotypic biomarker for impending relapse in acute myeloid leukemia","volume":"30","author":"Zeijlemaker","year":"2016","journal-title":"Leukemia"},{"key":"10.1016\/j.clml.2018.11.001_bib29","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1182\/bloodadvances.2018016378","article-title":"Evaluating measurable residual disease in acute myeloid leukemia","volume":"2","author":"Ravandi","year":"2018","journal-title":"Blood Adv"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501831351X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S215226501831351X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:31:58Z","timestamp":1761870718000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S215226501831351X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S215226501831351X"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2018.11.001","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of Peripheral Blast Clearance and Day 14 Bone Marrow Biopsy in Predicting Remission Status and Survival After 7+3 Induction in Acute Myeloid Leukemia","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2018.11.001","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}